Certara, Inc. (CERT)
| Market Cap | 1.61B +24.6% |
| Revenue (ttm) | 425.76M +13.3% |
| Net Income | -64.34M |
| EPS | -0.42 |
| Shares Out | 152.54M |
| PE Ratio | n/a |
| Forward PE | 27.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,054,207 |
| Open | 10.56 |
| Previous Close | 10.68 |
| Day's Range | 10.42 - 10.86 |
| 52-Week Range | 4.45 - 12.61 |
| Beta | 1.25 |
| Analysts | Buy |
| Price Target | 12.68 (+19.85%) |
| Earnings Date | Nov 5, 2026 |
About CERT
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scient... [Read more]
Financial Performance
In 2025, Certara's revenue was $418.84 million, an increase of 8.75% compared to the previous year's $385.15 million. Losses were -$1.60 million, -86.76% less than in 2024.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for CERT stock is "Buy." The 12-month stock price target is $12.68, which is an increase of 19.85% from the latest price.
News
Certara price target raised to $13 from $10 at UBS
UBS raised the firm’s price target on Certara (CERT) to $13 from $10 and keeps a Neutral rating on the shares.
Certara price target raised to $11.50 from $9 at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach raised the firm’s price target on Certara (CERT) to $11.50 from $9 and keeps an Equal Weight rating on the shares.
Certara price target raised to $11 from $7 at Baird
Baird raised the firm’s price target on Certara (CERT) to $11 from $7 and keeps a Neutral rating on the shares.
Certara price target raised to $12 from $9 at Barclays
Barclays raised the firm’s price target on Certara (CERT) to $12 from $9 and keeps an Equal Weight rating on the shares.
Certara price target raised to $12 from $8 at BMO Capital
BMO Capital raised the firm’s price target on Certara (CERT) to $12 from $8 and keeps a Market Perform rating on the shares.
Certara price target raised to $13 from $11 at Leerink
Leerink raised the firm’s price target on Certara (CERT) to $13 from $11 and keeps an Outperform rating on the shares.
Certara narrows FY26 adjusted EPS view to 31c-34c from 31c-36c
Consensus 34c. Narrows FY26 revenue view to up 2%-3% from $367M-$382M. “The third quarter reflects continued software momentum and the initial benefits of the operating actions we implemented in the…
Certara reports Q3 adjusted EPS 9c, consensus 9c
Reports Q3 revenue $94.9M, consensus $91.98M. “I am pleased with the steady progress we are making against our strategic, customer and operational objectives,” said Jon Resnick, Chief Executive Office...
Certara Earnings Call Transcript: Q3 2026
Q3 revenue grew 4% and Adjusted EBITDA rose 6%, led by 11% software growth as services remained soft. FY2026 revenue growth guidance is 2%-3%, with adjusted EPS of $0.31-$0.34.
Certara Earnings release: Q3 2026
Certara released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Certara Quarterly report: Q3 2026
Certara has published its Q3 2026 quarterly earnings report on November 5, 2026.
Certara Slides: Q3 2026
Certara has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 5, 2026.
Certara Reports Third Quarter 2026 Financial Results
Certara delivers a solid quarter with double-digit software revenue growth Updates 2026 financial outlook Appoints Grant Peterson Chief Product Officer Company to host conference call and webcast toda...
Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026
RADNOR, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third qu...
Certara price target raised to $12 from $9 at KeyBanc
KeyBanc raised the firm’s price target on Certara (CERT) to $12 from $9 and keeps an Overweight rating on the shares. Into the setup for Q3 earnings, the firm saw…
Certara price target raised to $11 from $9 at TD Cowen
TD Cowen raised the firm’s price target on Certara (CERT) to $11 from $9 and keeps a Buy rating on the shares. The firm adjusted targets in the life science…
Certara price target raised to $9 from $7.50 at Barclays
Barclays analyst Luke Sergott raised the firm’s price target on Certara (CERT) to $9 from $7.50 and keeps an Equal Weight rating on the shares. The firm adjusted targets in…
Certara resumed with a Neutral at UBS
UBS resumed coverage of Certara (CERT) with a Neutral rating and $10 price target UBS assumed coverage of the contract research organization industry with a constructive view on fundamentals, citing…
Certara price target raised to $7 from $6 at Baird
Baird raised the firm’s price target on Certara (CERT) to $7 from $6 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results which…
Certara price target lowered to $9 from $10 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Certara (CERT) to $9 from $10 and keeps an Equal Weight rating on the shares.
Certara price target raised to $7.50 from $6.50 at Barclays
Barclays raised the firm’s price target on Certara (CERT) to $7.50 from $6.50 and keeps an Equal Weight rating on the shares.
Certara Earnings Call Transcript: Q2 2026
Q2 2026 saw 1% revenue growth, with software up 4% and services down 3%. Guidance for 2026 remains at 0%–4% revenue growth, with software expected to outperform. Strategic actions included a divestiture, cost reductions, and new leadership, while AI integration and international expansion are driving future growth.
Certara Earnings release: Q2 2026
Certara released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Certara Quarterly report: Q2 2026
Certara has published its Q2 2026 quarterly earnings report on August 4, 2026.
Certara Slides: Q2 2026
Certara has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.